| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |